Identification of Molecular Targets and Anti-Cancer Agents in GBM: New Perspectives for Cancer Therapy.

The authors of the present literature piece were invited to participate in the present Special Issue at the beginning of 2022, and we were all very enthusiastic at the prospect of assembling a series of articles on new molecular targets and anti-cancer agents in glioblastoma multiforme (GBM) [...].